학술논문
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Document Type
Article
Author
Wise, D.R.; Deng, J.; Febles, V.A.; Balar, A.V.; Economides, M.P.; Griglun, S.; Leis, D.; Yang, N.; Aranchiy, V.; Machado, S.; Waalkes, E.; Gargano, G.; Soamchand, N.; Puranik, A.; Wong, K.-K.; Pachynski, R.K.; Denmeade, S.R.; Aggarwal, R.R.; Loomis, C.; Selvaraj, S.; Haas, M.; Kagey, M.H.; Newman, W.; Baum, J.; Sirard, C.A.; Troxel, A.B.; Chattopadhyay, P.; Fedal, E.; Deng, F.-M.; Ren, Q.; Chiriboga, L.; Melamed, J.
Source
In: Prostate Cancer and Prostatic Diseases . (Prostate Cancer and Prostatic Diseases, 2024)
Subject
Language
English
ISSN
14765608
13657852
13657852